Engineers at the University of Cambridge have built a low-cost optical sensor that they say brings the precision of laboratory-grade instruments into a device small enough to wear on the wrist. The chip, which costs about $10 to produce, is being presented as a step toward continuous, non-invasive health monitoring outside hospitals and clinics.
In tests, the sensor identified foods, plastics and medicines with 100 percent accuracy, according to the research team. The device also demonstrated the ability to monitor blood glucose, alcohol and other health markers without drawing blood or piercing the skin — a capability that has long been a goal for wearable medical technology.
The work sits at the intersection of photonics, materials science and consumer electronics. Optical sensing works by measuring how light interacts with a sample, and laboratory versions of such instruments are typically bulky, expensive and confined to specialized facilities. Shrinking that capability into a chip costing a few dollars could change where and how chemical analysis happens.
For patients with diabetes, non-invasive glucose tracking would remove the need for finger-prick tests or implanted sensors, both of which carry cost, discomfort and maintenance burdens. Alcohol monitoring could similarly move from breathalyzers and blood draws to a continuous wearable signal, with potential applications in clinical care, workplace safety and research.
The ability to distinguish foods and plastics with perfect accuracy in the reported tests also points to broader uses beyond medicine. A wearable or handheld sensor that can identify materials could support dietary tracking, allergen detection, recycling sorting and quality control in supply chains.
Cambridge researchers describe the device as delivering laboratory-level precision in a format suited to wearable technology. That framing places the chip in a crowded field of efforts to push diagnostics out of centralized labs and into everyday settings, where results can be gathered continuously rather than at occasional appointments.
Key questions remain about how the sensor performs outside controlled test conditions, how it handles the variability of human skin and body chemistry, and what regulatory path a wearable diagnostic would need to follow. The reported results establish a proof of concept; translation into approved consumer or clinical products would require further validation.
Cost is central to the project's promise. At roughly $10 per unit, the sensor could be embedded in devices at a price point accessible to mass markets, rather than remaining a premium tool for specialized clinics. Lower component costs have repeatedly been the trigger for widening access to diagnostic technology.
The development also reflects a wider convergence between consumer electronics and medical instrumentation. Smartwatches already track heart rate, blood oxygen and sleep patterns; adding molecular-level sensing would extend wearables from physiological signals toward chemical analysis, a far more demanding technical problem.
For now, the Cambridge team's chip offers a concrete demonstration that sophisticated optical measurement can be miniaturized and made cheaply. Whether it becomes the basis of a wrist-worn medical lab will depend on the engineering and clinical work that follows.
16
